Antitumor activity and immunological mechanisms of recombinant BCG
10.3969/j.issn.1000-484X.2015.08.013
- VernacularTitle:重组BCG的抑瘤活性及免疫学机制研究
- Author:
Qingjie XUE
;
Xiuzhen LI
;
Yunqing LI
;
Yuanyuan YANG
;
Wenjie HU
;
Honghua ZHANG
;
Shigen LI
- Publication Type:Journal Article
- Keywords:
rBCG;
Anti-tumor;
Cellular immune;
EB virus
- From:
Chinese Journal of Immunology
2015;(8):1060-1065
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To study the antitumor activity and immunological mechanisms of rBCG including GM-CSF and EB virus LMP2A gene fusion.Methods: Animal models of EB virus-positive tumors was built.The formation time of tumors in mice,survival time,tumor weight was analyzed to detect rBCG anti-tumor activity;ELISA method was used to detect the specific antibodies which was produced in the mice stimulated by rBCG,specific CTL killing effect was detected by lactic dehydrogenase assay,ELISPOT was used to assay the secretion of IFN-γand flow cytometry, HE staining of tumor tissue was used to detected lymphocyte infiltration in mice immunized with recombinant BCG.Statistical methods were used for rBCG immunization effect preliminary analysis and evaluation.Results:Comparing to other control,tumor formation time was significantly delayed and tumor growth was slow, survival time of mice prolonged .ELISA test results showed that the rBCG immunization groups of mice could produce specific IgG antibodies of GM-CSF and LMP2A.Specific CTL activity was detected in mice immunized with rBCG.IFN-γsecretion was detected by ELISPOT method, flow cytometry and morphological observation detected tumor tissue infiltration of lymphocytes growth in mice immunized with rBCG.Conclusion:The rBCG induced a humoral and cellular immune responses and induced C57BL/6 mice to produce a strong anti-tumor effect and the EB virus-positive tumor cells was significantly inhibited.
